Keros Therapeutics director Anne Prener reports sale of common shares worth $5,619.46
KROS•Director Anne Prener sold 574 Keros Therapeutics shares at $9.79 each on Nov. 12, leaving her with 13,212 shares, a Form 4 dated Nov. 16 showed.
1. Share sale
Anne Prener sold 574 shares of Keros Therapeutics common stock at $9.79 each on Nov. 12. After the sale, she directly owned 13,212 shares, according to a Form 4 dated Nov. 16.




